ClearBridge Investments’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,526,790
Closed -$20.7M 785
2020
Q2
$20.7M Buy
1,526,790
+54,354
+4% +$738K 0.02% 404
2020
Q1
$11.2M Sell
1,472,436
-164,645
-10% -$1.25M 0.01% 462
2019
Q4
$10.4M Buy
1,637,081
+370,302
+29% +$2.35M 0.01% 544
2019
Q3
$4.97M Sell
1,266,779
-121,549
-9% -$476K ﹤0.01% 588
2019
Q2
$6.72M Buy
1,388,328
+130,992
+10% +$634K 0.01% 555
2019
Q1
$10.3M Buy
1,257,336
+41,450
+3% +$339K 0.01% 530
2018
Q4
$6.72M Buy
1,215,886
+199,360
+20% +$1.1M 0.01% 558
2018
Q3
$8.98M Buy
1,016,526
+1,016,397
+787,905% +$8.97M 0.01% 554
2018
Q2
$1K Buy
+129
New +$1K ﹤0.01% 1121